Abstract
Background: In vivo studies are crucial for the identification of pathogenic cellular and molecular mechanisms. Animal models are especially relevant due to their systems' integrity and evaluation of multiple translational parameters.
Objective: This review presents a general panorama of the pharmacological and genetic seizure models using this species as a platform for disease modeling and accelerated drug discovery.
Method: We performed a literature review about the use of zebrafish to model seizures and epilepsy.
Conclusion: The zebrafish is a prominent model organism with considerable degree of physiological and genetic conservation especially suitable for behavioral and electrophysiological investigation of seizure mechanisms. Its sensitivity to chemoconvulsant and straightforwardness in modern genetic approaches supports its competitive contribution to epilepsy research.
Keywords: Antiepileptic drugs, drug discovery, epilepsy, genetic model, pharmacological model, seizure, zebrafish.
Current Psychopharmacology
Title:Zebrafish as a Platform for Studies on Seizures and Epilepsy
Volume: 5
Author(s): Rosane S. da Silva, Carla D. Bonan and Monica R.M. Vianna
Affiliation:
Keywords: Antiepileptic drugs, drug discovery, epilepsy, genetic model, pharmacological model, seizure, zebrafish.
Abstract: Background: In vivo studies are crucial for the identification of pathogenic cellular and molecular mechanisms. Animal models are especially relevant due to their systems' integrity and evaluation of multiple translational parameters.
Objective: This review presents a general panorama of the pharmacological and genetic seizure models using this species as a platform for disease modeling and accelerated drug discovery.
Method: We performed a literature review about the use of zebrafish to model seizures and epilepsy.
Conclusion: The zebrafish is a prominent model organism with considerable degree of physiological and genetic conservation especially suitable for behavioral and electrophysiological investigation of seizure mechanisms. Its sensitivity to chemoconvulsant and straightforwardness in modern genetic approaches supports its competitive contribution to epilepsy research.
Export Options
About this article
Cite this article as:
Silva S. da Rosane, Bonan D. Carla and Vianna R.M. Monica, Zebrafish as a Platform for Studies on Seizures and Epilepsy, Current Psychopharmacology 2016; 5 (2) . https://dx.doi.org/10.2174/2211556005666160526112030
DOI https://dx.doi.org/10.2174/2211556005666160526112030 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting the Brain: Advances in Drug Delivery
Current Pharmaceutical Biotechnology Recent Advances in the Treatment of Amyotrophic Lateral Sclerosis. Emphasis on Kynurenine Pathway Inhibitors
Central Nervous System Agents in Medicinal Chemistry Commentary: Gut Microbiota and Brain Function: A New Target for Brain Diseases?
CNS & Neurological Disorders - Drug Targets Safety of Cabergoline in the Management of Pituitary Prolactin-Induced Symptoms with Patients Treated with Atypical Neuroleptics
Current Drug Safety Current Trends in the Application of Nanoparticles in Drug Delivery
Current Medicinal Chemistry Is there a Rational Approach for Increasing Drug Specificity? Considerations on CNS Target Choice and Validation
Recent Patents on CNS Drug Discovery (Discontinued) SkQ-1 Regulates Xanthine Oxidase Activity in the Settings of Epilepsic Seizures in Rats
Neuroscience and Biomedical Engineering (Discontinued) Revised Genetic Classification of Limb Girdle Muscular Dystrophies
Current Molecular Medicine Multidrug-Resistance (MDR) Proteins Develops Refractory Epilepsy Phenotype:Clinical and Experimental Evidences
Current Drug Therapy Persistent Current Blockers of Voltage-Gated Sodium Channels: A Clinical Opportunity for Controlling Metastatic Disease
Recent Patents on Anti-Cancer Drug Discovery Therapeutic Potential of Hepatocyte Growth Factor for Treating Neurological Diseases
Current Drug Therapy Does Mechanism of Drug Action Matter to Inform Rational Polytherapy in Epilepsy?
CNS & Neurological Disorders - Drug Targets Diagnostic Approach to Mitochondrial Disorders: the Need for a Reliable Biomarker
Current Molecular Medicine PDZ Domain-mediated Protein Interactions: Therapeutic Targets in Neurological Disorders
Current Medicinal Chemistry Safety and Efficacy of Melatonin in Pediatric Migraine Prophylaxis
Current Drug Safety The Connections Among Autophagy, Inflammasome and Mitochondria
Current Drug Targets Juvenile Neuronal Ceroid-Lipofuscinosis (Batten Disease): A Brief Review and Update
Current Molecular Medicine Subject Index To Volume 1
Recent Patents on CNS Drug Discovery (Discontinued) Serum Insulin Degrading Enzyme Level and Other Factors in Type 2 Diabetic Patients with Mild Cognitive Impairment
Current Alzheimer Research Is VEGF a Key Target of Cotinine and Other Potential Therapies Against Alzheimer Disease?
Current Alzheimer Research